Immuno-Oncology Pioneer Dr. Michael Kalos Joins Kos Biotechnology Partners as Venture Part

September 10, 2026

/PRNewswire/ — Kos Biotechnology Partners, a global life sciences investment firm, today announced the appointment of renowned immuno-oncology leader Michael…

Search

RECENT PRESS RELEASES

Audi Wants EV Lessees To Keep Their Zero-Emission Vehicles With Up to $10,000 Off

SWI Editorial Staff2026-09-10T07:03:05-07:00September 10, 2026|

Quip Network Turns Quantum Computers Into Blockchain Randomness Machines With New Ethereum Collection

SWI Editorial Staff2026-09-10T07:02:15-07:00September 10, 2026|

Are utility-scale wind and solar decreasing property values? It probably depends on where you live

SWI Editorial Staff2026-09-10T07:02:06-07:00September 10, 2026|

South Korea is nearing a $100 billion nuclear and gas energy investment deal with the U.S.

SWI Editorial Staff2026-09-10T07:01:57-07:00September 10, 2026|

TfL environment plan with more than 70 actions to cut emissions

SWI Editorial Staff2026-09-10T07:01:19-07:00September 10, 2026|

What will the Fed do next? Investors search for answers

SWI Editorial Staff2026-09-10T07:01:00-07:00September 10, 2026|